Explore our materials

Andean Pacific Workshop on HIV & Hepatitis 2017

HIV in Women - PTMCT - pregnancy | Isabel Cassetti, MD

Francesca Ceccherini-Silberstein

PhD

Andean Pacific Workshop on HIV & Hepatitis 2017

Strategies for hepatitis C elimination | Francesca Ceccherini– Silberstein, PhD

Mark Nelson

MD, MBBS, FRCP

Andean Pacific Workshop on HIV & Hepatitis 2017

Implementation of DAAs in clinical management | Mark Nelson, MD

Andean Pacific Workshop on HIV & Hepatitis 2017

Local situation in LA (epidemiology / treatment options) | Jorge Contreras, MD

Susana Cabrera

Andean Pacific Workshop on HIV & Hepatitis 2017

Early diagnosis & testing | Susana Cabrera, MD

Francesca Ceccherini-Silberstein

PhD

Andean Pacific Workshop on HIV & Hepatitis 2017

Clinical Implications of low level viremia/ failure and resistance | Francesca Ceccherini– Silberstein, PhD

APCdlT

Ana Paulina Celi de la Torre

Andean Pacific Workshop on HIV & Hepatitis 2017

Difficult to reach populations in Latin America | Ana Paulina Celi de la Torre, MD

Alejandro Afani

Andean Pacific Workshop on HIV & Hepatitis 2017

WHO Target 90-90-90 : Achievable for Latin America | Alejandro Afani, MD

Marcelo Wolff

MD, FACP, FIDSA

Andean Pacific Workshop on HIV & Hepatitis 2017

HIV in Latin America: 35 years later | Marcelo Wolff, MD, FACP, FIDSA

International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016

Specific Complex Interactions (mechanic presentation) | David Burger, PharmD, PhD

International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016

Backing up clinical data with modelling | Marco Siccardi, PhD